IP Library Granted Patent US 7,264,825
Granted Patent B2
US 7,264,825 · App. 10/600,557 · Granted Sep 4, 2007

Pharmaceutical preparation with retarding active ingredient release, method for its production and its use

Assignee: Herseus Kulzer GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,264,825
App. No.
10/600,557
Granted
Sep 4, 2007
Kind
B2
Abstract

The invention describes pharmaceutical preparations with retarding active ingredient release, which consist of mixtures of powdery teicoplanin and at least one powdery, water soluble salt form of gentamicin, clindamycin, kanamycin, amikacin, tobramycin, vancomycin, moxifloxacin and ciprofloxacin and an inorganic and/or organic adjuvant. The pharmaceutical preparations are used as permanent or as temporary implants in the form of tablets, molded bodies, fibers and granules.

Claims (10)

1. A dry pharmaceutical preparation comprising a dry mixture of powdery teicoplanin and at least one powdery, water soluble salt form of at least one of gentamicin, clindamycin, kanamycin, amikacin, tobramycin, vancomycin, moxifloxacin and ciprofloxacin and an inorganic and/or organic adjuvant.

2. The dry pharmaceutical preparation pursuant to claim 1 , which contains calcium carbonate, calcium sulfate dihydrate, tricalcium phosphate and/or hydroxylapatite as the inorganic adjuvant.

3. The dry pharmaceutical preparation pursuant to claim 1 , which contains polyesters of at least one of lactic acid, glycolic acid, 5-hydroxy valerie acid, 6-hydroxy caproic acid and co-polymers thereof as organic adjuvants.

4. The dry pharmaceutical preparation pursuant to claim 1 , which is in the form of one of tablets, molded bodies, fibers and granules.

5. The dry pharmaceutical preparation pursuant to claim 1 , comprising a combination of polymerizable methacrylic acid esters and mixtures consisting of powdery teicoplanin and at least one powdery, water soluble salt form of at least one of gentamicin, clindamycin, kanamycin, amikacin, tobramycin, vancomycin, moxifloxacin and ciprofloxacin formed and polymerized into a molded body.

6. The dry pharmaceutical preparation pursuant to claim 1 , wherein the mixture is part of a resorbable and/or of non-resorbable coating, which has been applied to non-metallic and metallic implants.

7. The dry pharmaceutical preparation pursuant to claim 1 , wherein before being cured inorganic calcium phosphate bone cements and plaster mixtures are admixed to mixtures consisting of powdery teicoplanin and at least one powdery, water soluble salt form of at least one of gentamicin, clindamycin, kanamycin, amikacin, tobramycin, vancomycin, moxifloxacin and/or ciprofloxacin.

8. A permanent or temporary implant comprising a dry pharmaceutical preparation pursuant to claim 1 in the form of one of tablets, molded bodies, fibers and granules.

9. A method of treating a bacterial infection in a patient in need thereof comprising administering to said patient a pharmaceutical preparation pursuant to claim 1 .

10. A method of preparing the dry pharmaceutical preparation according to claim 1 , said method comprising dry mixing powdery teicoplanin and at least one powdery, water soluble salt form of at least one of gentamicin, clindamycin, kanamycin, amikacin, tobramycin, vancomycin, moxifloxacin and ciprofloxacin and an inorganic and/or organic adjuvant.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2014
From: HERAEUS KULZER GMBH
To: HERAEUS MEDICAL GMBH
Reel/Frame 031905/0674 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2003
From: VOGT, SEBASTIAN DR.; SCHNABELRAUCH, MATTHIAS DR.; KUHN, KLAUS-DIETER DR.
To: HERAEUS KULZER GMBH & CO. KG
Reel/Frame 014077/0517 →
Priority Claims (1)
DE 102 27 914 · Jun 21, 2002 · national
Continuity (1)
Related Publication 20040052841A1 · Mar 18, 2004